Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). In 2022, the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) jointly proposed new classification criteria for AAV (the 2022 ACR/EULAR criteria). In this review, we briefly summarize the 2022 ACR/EULAR criteria for GPA, MPA, and EGPA, and introduce our clinical experience with applying them to patients who were previously diagnosed with AAV based on three criteria: firstly, the classification criteria for GPA and EGPA proposed by the ACR in 1990; secondly, the algorithm for the classification of AAV and polyarteritis nodosa proposed by the European Medi cines Agency algorithm in 2007 (the 2007 EMA algorithm); and thirdly, the revised International Chapel Hill Consensus Confer ence nomenclature of vasculitides in 2012 (the 2012 CHCC definitions). We found that concordance rate was highest in patients with MPA (96.6%), followed by those with EGPA (86.3%) and GPA (73.8%). In addition, compared to previous criteria, we noted several issues of the undervalued or overvalued items in the 2022 ACR/EULAR criteria for classifying AAV and provided several suggestions. To increase the diagnostic accuracy and reduce the discordance rate among the new and previous criteria for AAV, we suggest that the previous criteria should be considered together with the 2022 ACR/EULAR criteria when applying the classifi cation criteria for AAV to patients suspected of AAV.
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). In 2022, the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) jointly proposed new classification criteria for AAV (the 2022 ACR/EULAR criteria). In this review, we briefly summarize the 2022 ACR/EULAR criteria for GPA, MPA, and EGPA, and introduce our clinical experience with applying them to patients who were previously diagnosed with AAV based on three criteria: firstly, the classification criteria for GPA and EGPA proposed by the ACR in 1990; secondly, the algorithm for the classification of AAV and polyarteritis nodosa proposed by the European Medi cines Agency algorithm in 2007 (the 2007 EMA algorithm); and thirdly, the revised International Chapel Hill Consensus Confer ence nomenclature of vasculitides in 2012 (the 2012 CHCC definitions). We found that concordance rate was highest in patients with MPA (96.6%), followed by those with EGPA (86.3%) and GPA (73.8%). In addition, compared to previous criteria, we noted several issues of the undervalued or overvalued items in the 2022 ACR/EULAR criteria for classifying AAV and provided several suggestions. To increase the diagnostic accuracy and reduce the discordance rate among the new and previous criteria for AAV, we suggest that the previous criteria should be considered together with the 2022 ACR/EULAR criteria when applying the classifi cation criteria for AAV to patients suspected of AAV.
참고문헌 (32)
- Jennette JC, "2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides", Arthritis Rheum, 65, pp.1~11 (2013)
- Jennette JC, "Nomenclature of systemic vasculitides. Proposal of an international consensus conference", Arthritis Rheum, 37, pp.187~192 (1994)
- 최찬범, "Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review", Yonsei Medical Journal, 60(1), pp.10~21 (2019), 연세대학교의과대학[DOI]
- Watts R, "Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies", Ann Rheum Dis, 66, pp.222~227 (2007)
- Cornec D, "ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients", Nat Rev Rheumatol, 12, pp.570~579 (2016)
- Kitching AR, "ANCA-associated vasculitis", Nat Rev Dis Primers, 6, pp.71~ (2020)
- Jennette JC, "Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease", Nat Rev Rheumatol, 10, pp.463~473 (2014)
- Mukhtyar C, "Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis : a systematic review by the European League Against Rheumatism systemic vasculitis task force", Ann Rheum Dis, 67, pp.1004~1010 (2008)
- Chaigne B, "Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides", Clin Exp Rheumatol, 34(3 Suppl 97), pp.S121~S128 (2016)
- Elefante E, "One year in review 2017 : systemic vasculitis", Clin Exp Rheumatol, 35(Suppl 103), pp.5~26 (2017)
- Tan JA, "Mortality in ANCA-associated vasculitis : ameta-analysis of observational studies", Ann Rheum Dis, 76, pp.1566~1574 (2017)
- Chung SA, "2021 American College of Rheumatology", Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis, 2021, pp.73, 1366~1383
- Leavitt RY, "The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis", Arthritis Rheum, 33, pp.1101~1107 (1990)
- Masi AT, "The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome(allergic granulomatosis and angiitis)", Arthritis Rheum, 33, pp.1094~1100 (1990)
- Robson JC, "2022 American College of Rheumatology", European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis, 2022, pp.81, 315~320
- Suppiah R, "2022 American College of Rheumatology", European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis, 2022, pp.81, 321~326
- Grayson PC, "2022 American College of Rheumatology", European Alliance of Associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis, 2022, pp.81, 309~314
- Pyo JY, "Reclassification of previously diagnosed GPA patients using the 2022 ACR", EULAR classification criteria, 2022, ~
- Pyo JY, "Application of the 2022ACR", EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis, 2022, ~
- Pyo JY, "The reclassification of patients with previously diagnosed eosinophilic granulomatosis with polyangiitis based on the 2022 ACR", EULAR criteria for antineutrophil cytoplasmic antibody-associated vasculitis, 2022, ~
- Kesel N, "Cartilage destruction in granulomatosis with polyangiitis(Wegener's granulomatosis)is mediated by human fibroblasts after transplantation into immunodeficient mice", Am J Pathol, 180, pp.2144~2155 (2012)
- Geetha D, "ANCA-associated vasculitis : core curriculum 2020", Am J Kidney Dis, 75, pp.124~137 (2020)
- Berden AE, "Histopathologic classification of ANCA-associated glomerulonephritis", J Am Soc Nephrol, 21, pp.1628~1636 (2010)
- Wijsenbeek M, "Interstitial lung diseases", Lancet, 400, pp.769~786 (2022)
- Argyropoulou OD, "Occurrence and antigenic specificity of perinuclear anti-neutrophil cytoplasmic antibodies(PANCA)in systemic autoimmune diseases", Cells, 10, pp.2128~ (2021)
- 최찬범, "Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients", Yonsei Medical Journal, 60(8), pp.705~712 (2019), 연세대학교의과대학[DOI]
- Vaglio A, "Churg-Strauss syndrome", Kidney Int, 76, pp.1006~1011 (2009)
- Yoo J, "The utility of the ACR", EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis, 2018, pp.36(Suppl 111), S85~S87
- Millet A, "Antineutrophil cytoplasmic antibody-associated vasculitides : is it time to split up the group?", Ann Rheum Dis, 72, pp.1273~1279 (2013)
- Mahmood SB, "Anti-neutrophil cytoplasmic antibody-positive eosinophilic granulomatosis with polyangiitis : can it cause membranous nephropathy?", Scand J Rheumatol, 48, pp.256~257 (2019)
- 표정윤, "The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis", Yonsei Medical Journal, 62(6), pp.494~502 (2021), 연세대학교의과대학[DOI]
- 안성수, "Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea", Yonsei Medical Journal, 62(4), pp.279~287 (2021), 연세대학교의과대학[DOI]